AngioDynamics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales
AngioDynamics, Inc. (ANGO) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales of $0 for the 12-month period ending 2019-05-31, per its 10-K filed 2020-08-10.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales · last filed 2020-08-10
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, sales for the quarter ending 2019-05-31 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, sales for the quarter ending 2019-02-28 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, sales for the quarter ending 2018-02-28 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, sales for the quarter ending 2017-11-30 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, sales for fiscal 2019 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, sales for fiscal 2017 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales 12 month |
|---|---|---|---|---|
| 2019-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $0.00 derived: sum of 2 quarters · filed 2020-08-10 | $0.00 10-K · filed 2020-08-10 | |
| 2019-02-28 | $0.00 10-Q · filed 2019-04-02 | $0.00 10-Q · filed 2019-04-02 | ||
| 2018-02-28 | $0.00 10-Q · filed 2018-04-05 | $0.00 derived: sum of 2 quarters · filed 2018-04-05 | ||
| 2017-11-30 | $0.00 10-Q · filed 2018-01-05 | |||
| 2017-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-23 | $0.00 derived: sum of 2 quarters · filed 2018-07-23 | $0.00 derived: sum of 3 quarters · filed 2018-07-23 | $0.00 10-K · filed 2018-07-23 |
| 2017-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-03 | $0.00 derived: sum of 2 quarters · filed 2017-04-03 | $0.00 10-Q · filed 2017-04-03 | |
| 2016-11-30 | $0.00 10-Q · filed 2017-01-06 | $0.00 10-Q · filed 2017-01-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |